News

MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) a company focused on…

2 years ago

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 December 2023, 07:00 am CET Pending FDA approval, alfapump could become the first active…

2 years ago

Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares

TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) today announced the pricing…

2 years ago

LiveCare Inc. Expands Telehealth Services Across Multiple States, Welcomes Dr. Nina Patel, and Celebrates Patient Acquisition Milestones

Venice, FL, USA, Dec. 27, 2023 (GLOBE NEWSWIRE) --  LiveCare Inc. (OTC:LVCE), a prominent leader in telehealth and remote patient…

2 years ago

Quipt Home Medical Corp. Announces Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus

CINCINNATI, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based…

2 years ago

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and…

2 years ago

Profound Medical Announces Proposed Public Offering of Common Shares

TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) is pleased to announce…

2 years ago

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer…

2 years ago

Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference

SEATTLE, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…

2 years ago

Fresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15th

New record date expected to be January 11, 2024 Company intends to seek judicial dissolution if the liquidation and dissolution…

2 years ago